|Publication number||US3228894 A|
|Publication date||Jan 11, 1966|
|Filing date||Dec 24, 1962|
|Priority date||Dec 24, 1962|
|Publication number||US 3228894 A, US 3228894A, US-A-3228894, US3228894 A, US3228894A|
|Inventors||Jeckel Norman C|
|Original Assignee||Us Catheter & Instr Corp|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (8), Referenced by (24), Classifications (10)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent C 3,228,894 FLUORQCARBON TUNGSTEN MEMBERS Norman C. Jeckel, Glens Falls, N.Y., assignor to United States Catheter 81 Instrument Corporation, Glens Falls, N.Y., a corporation of New York No Drawing. Filed Dec. 24, 1962, Ser. No. 246,684 Claims. (Cl. 252478) This invention relates to new and useful improvements in radiopaque fluorocarbon tubing and more particularly seeks to provide a cardiac catheter composed primarily of fluorocarbon and tungsten.
The unusual properties of the fiuorocarbons, particularly polytetrafiuoroethylene, are ideal for forming extruded tubing such as cardiac or other catheters because of the following properties, among others. First, within the temperature range of 70-110 F., there is no appreciable change in degree of stiffness. Second, the curved distal tips are heat set at over 600 F. and do not flatten out at body temperature, thus making introduction easier. Third, the lowest coeflicient of friction of any known materials makes them less traumatic and easier to introduce. Fourth, their non-wettable surfaces reduce the tendency of the catheter to coagulate blood. Fifth, their zero absorption of water as liquid or vapor causes catheters to retain their length and hardness longer than most other materials. Sixth, they are unaffected by temperature up to 600 F. and thus may be repeatedly boiled or autoclaved with no harmful effect. The autoclaving causes no softening and need not be followed by drying because no moisture can be absorbed as already pointed out. Seventh, nothing sticks to fluorocarbons, not even strong adhesives, and thus they are easy to clean and have much less tendency to collect deposits of any kind. Eighth, the lumen is extremely smooth and friction-free so as to be ideal for injections where the lowest possible resistance to flow is necessary. Ninth, the materials are non-toxic, inert and have a lower order of tissue reactivity.
It is essential in most instances for cardiac catheters to be radiopaque in order to follow the path of introduction on the fluoroscope. Accordingly, conventional radiopaque metals such as tin, lead and bismuth have been added to the fluorocarbons. However, the powdered polytetrafluoroethylene is extruded at room temperature but then sintered at 650-800 F., generally 750, whereupon these metals are discolored and thereafter deteriorate relatively rapidly so that the catheters tend to split, crack, etc., under pressure and mechanical distortion. Furthermore, these metals are medically toxic.
It is, therefore, an object of this invention to provide a radiopaque fluorocarbon tube which will not discolor during sintering, nor deteriorate thereafter and which will contain no medically toxic materials.
I have found that these objects may be attained by incorporating tungsten Within the fluorocarbon composition of cardiac catheters or other radiopaque members.
With the above objects and features in view, the nature of which will be more apparent, the invention will be more fully understood by reference to the accompanying detailed description and the appended claims.
To 80 parts by weight of polytetrafluoroethylene powder is intimately mixed 20 parts of tungsten powder and suflicient mineral spirits solvent to make a paste for extrusion. This is then extruded at room temperature into the desired cardiac catheter shape and subsequently sintered at about 750 F. to produce a non-toxic catheter 3,228,894 Patented Jan. 11, 1966 having excellent flex-resistance with no deterioration or discoloration.
It is obvious that in addition to cardiac catheters, any tubular, rod or other shape extrusion where radiopacity is desired may be formed. Extrusion may be from a melted liquid (FEP) or the extrusion and sintering may be a simultaneous operation starting with a dry mixture of materials if sufficient pressure and proper temperature is used. The sintering temperature will be that normal for polytetrafluoroethylene which presently ranges from 650-800 F. The invention is applicable to any of the fluorocarbons, e.g. polytetrafluoroethylene (TFE), fluorinated ethylene propylene (FEP), (both sold und r Du Ponts registered trademark, Teflon), polytrifluorochloroethylene (sold under Minnesota Mining and Manufacturing Companys trademark, EL-F), and other chlorinated fluorocarbons.
Since tungsten is very dense (specific gravity of 19.3), its relative volume in the composition will be much less than its relative weight. The range of tungsten by weight is preferably from 5 to 30% of the total composition. Amounts outside this range are usable but. the radiopacity is relatively weak below 5% and the mechanical properties of the fluorocarbon is weakened above 30%.
1. A radiopaque material comprising a solid fluorocarbon polymer and sufficient tungsten intimately mixed therewith to render said material radiopaque.
2. A radiopaque extruded member comprising a solid fluorocarbon polymer and suflicient tungsten intimately mixed therewith to render said material radiopaque.
3. A radiopaque extruded and sintered tube member formed from a fluorocarbon polymer powder and 5 to 30% by weight of tungsten powder intimately mixed therewith.
4. The member of claim 3 wherein said tube is a cardiac catheter.
5. The member of claim 4 wherein said fluorocarbon is polytetrafluoroethylene.
6. The member of claim 4 having about 20% of said tungsten.
7. A method for forming a radiopaque tube comprising intimately mixing fluorocarbon polymer powder and sufiicient tungsten powder to render said tube radiopaque, extruding said mixed powder as said tube, and sintering said extruded tube at about 650800 F.
8. The method of claim 7 wherein said tungsten comprises 5 to 30% by weight of the total powder content.
9. The method of claim 8 wherein said fluorocarbon is polytetrafluoroethylene.
10. The method of claim 9 wherein said tungsten is about 20% References Cited by the Examiner UNITED STATES PATENTS 2,230,654 2/ 1941 Plunkett 260-33.8 2,644,804 7/1953 Rubin 260-33.8 2,752,637 7/1956 Walker et al. 264-119 2,857,915 10/1956 Sheridan 128349 2,985,918 5/1961 Moore et al 260-338 3,075,925 1/1963 Dunegan 252478 3,089,866 5/1963 Crawford 26087.5 X 3,094,585 6/ 1963 Rudner 264-127 X CARL D. QUARFORTH, Primary Examiner.
REUBEN EPSTEIN, Examiner.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2230654 *||Jul 1, 1939||Feb 4, 1941||Kinetic Chemicals Inc||Tetrafluoroethylene polymers|
|US2644804 *||Apr 22, 1950||Jul 7, 1953||Kellogg M W Co||Packing composition containing polytrifluorochloroe thylene and an inorganic antifriction agent|
|US2752637 *||Jul 1, 1954||Jul 3, 1956||Resistoflex Corp||Extrusion of polytetrafluoroethylene|
|US2857915 *||Apr 2, 1956||Oct 28, 1958||Sheridan David S||X-ray catheter|
|US2985918 *||Jan 20, 1959||May 30, 1961||Raybestos Manhattan Inc||Method for forming shaped lengths of tetrafluoroethylene polymers having a cellular structure|
|US3075925 *||Dec 21, 1960||Jan 29, 1963||Harold L Dunegan||Radiation shielding composition|
|US3089866 *||May 25, 1956||May 14, 1963||Minnesota Mining & Mfg||Process for the preparation of fluorine-containing polymers|
|US3094585 *||Apr 16, 1951||Jun 18, 1963||Garlock Inc||Fluorocarbon resin mixtures and metal to plastic bonding|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3608555 *||Dec 31, 1968||Sep 28, 1971||Chemplast Inc||Radio opaque and optically transparent tubing|
|US3612038 *||Feb 3, 1969||Oct 12, 1971||Becton Dickinson Co||Preformable catheter package assembly and method of preforming|
|US3815608 *||Mar 10, 1972||Jun 11, 1974||East West Med Prod||Retaining catheter|
|US3818229 *||Dec 21, 1970||Jun 18, 1974||Univ Illinois||Radiopaque agents comprising brominated perfluorocarbons|
|US3829903 *||Mar 15, 1973||Aug 20, 1974||Dow Corning||Method of inhibiting blood clot on silicone rubber medical devices|
|US4182342 *||Apr 28, 1978||Jan 8, 1980||Med-Pro, Ltd.||Naso-gastric feeding device and method of inserting same|
|US4247510 *||Dec 10, 1979||Jan 27, 1981||Cefilac||Process for depositing an elastomeric or thermosetting bank on a support|
|US4469483 *||Aug 25, 1982||Sep 4, 1984||Baxter Travenol Laboratories, Inc.||Radiopaque catheter|
|US5147318 *||Mar 4, 1991||Sep 15, 1992||Board Of Regents, The University Of Texas System||Valved arterial catheter|
|US5336205 *||Feb 25, 1993||Aug 9, 1994||Target Therapeutics, Inc.||Flow directed catheter|
|US5538512 *||Jul 8, 1994||Jul 23, 1996||Zenzon; Wendy J.||Lubricious flow directed catheter|
|US5730733 *||May 31, 1996||Mar 24, 1998||Scimed Life Systems, Inc.||Flow assisted catheter|
|US5899892 *||Nov 7, 1997||May 4, 1999||Scimed Life Systems, Inc.||Catheter having distal fiber braid|
|US5947939 *||Mar 14, 1997||Sep 7, 1999||Scimed Life Systems, Inc.||Flow assisted catheter|
|US5961511 *||Oct 28, 1998||Oct 5, 1999||Scimed Life Systems, Inc.||Catheter having LCP reinforced distal portion|
|US6193705||Sep 3, 1999||Feb 27, 2001||Scimed Life Systems, Inc.||Flow assisted catheter|
|US7704245||Apr 13, 2004||Apr 27, 2010||Cook Incorporated||Large diameter delivery catheter/sheath|
|US7968038||Mar 8, 2010||Jun 28, 2011||Cook Medical Technologies Llc||Large diameter delivery catheter/sheath|
|US20040220549 *||Apr 13, 2004||Nov 4, 2004||Dittman Jay A.||Large diameter delivery catheter/sheath|
|US20050090802 *||Apr 26, 2004||Apr 28, 2005||Connors John J.Iii||Flexible sheath with varying durometer|
|US20100163159 *||Mar 8, 2010||Jul 1, 2010||Cook Incorporated||Large diameter delivery catheter/sheath|
|DE1965487A1 *||Dec 30, 1969||Nov 19, 1970||Chemplast Inc||Katheter und Verfahren zu seiner Herstellung|
|EP2561898A1||Aug 24, 2012||Feb 27, 2013||Cook Medical Technologies LLC||Medical balloon and balloon catheter assembly|
|WO1992015352A1 *||Mar 4, 1992||Sep 17, 1992||Board Of Regents, The University Of Texas System||Valved arterial catheter|
|U.S. Classification||252/478, 604/529, 264/127, 138/118, 524/440, 524/546, 523/112|